SAFE OUTCOMES WITH NOVEL ORAL ANTICOAGULANTS IN OBESE PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION FOR ATRIAL TACHYARRHYTHMIAS

Rachel M. Kaplan,Celso L. Diaz,Theresa Strzelczyk,Cindy You,Basil Saour,Michelle Fine,Amar Trivedi,Mark J. Shen,Prasongchai Sattayaprasert,Alexandru B. Chicos,Rishi Arora,Susan S. Kim,Albert C. Lin,Nishant Verma,Bradley P. Knight,Rod Passman

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 1|浏览11

暂无评分

摘要

Novel oral anticoagulants (NOACs) are used in patients undergoing direct-current cardioversion (DCCV) for atrial fibrillation and atrial flutter (AF/AFL). There are concerns about their efficacy and safety in severely obese patients as volume of distribution is related to weight and few such

查看译文

关键词

oral anticoagulants,electrical cardioversion,obese patients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要